Management Team

Boaz Brill, PhD

CEOBoaz Brill s


With over 25 years of experience in the high-tech industry, Boaz brings extensive leadership experience, motivating multi-disciplinary teams toward achieving challenging goals.   In his previous role as VP R&D and CTO of Nova Measuring Instruments (Nasdaq: NVMI), he led the development of Optical CD measurement technology from concept to market, resulting with >$100M in annual sales, 5 generations of products installed in the factories of top semiconductor manufacturers worldwide and over 40 US patents.  From the technology aspects, Boaz brings extensive experience in system engineering, optics, and algorithms.  Boaz is leading GluSense as CEO since 2011.

Boaz is a graduate of the prestigious Talpiot IDF program;  he received his Ph.D. in Physics from the Weizmann Institute of Science and holds an MBA from the University of Bradford (UK).



Uriel Barkai, PhD

Chief Scientific OfficerUriel_2

With over 30 years in the BioMed industry, Uriel has been directly involved with cell-based medical devices in the past 15 years, leading multiple R&D programs in various companies, including Beta-O2 and Carmel Biosensor.

Uriel holds a Ph.D. in Physiology from Tel-Aviv University and has been a visiting scientist in several leading universities in the US and Europe.



Itamar Weisman

VP R&DItamar_2


Itamar holds an MSc in Biology from the Hebrew University of Jerusalem.  He brings extensive experience in cell-line development and various characterization techniques.

In GluSense, Itamar leads the R&D group and is additionally responsible for the company’s pre-clinical and clinical programs.


Nimrod Kadim

VP Product DevelopmentNimrod Kadim


Nimrod brings over 20 years of experience in research & development in the medical device arena. Prior to joining GluSense Nimrod was Vice President of Research & Development at SLP where he managed the development of sleep diagnostics devices. Previously he was Director of Development at BioControl where he guided the development of Class III active implantable stimulators for the treatment of heart failure and epilepsy. And prior, he managed the development of medical devices in the field of cardiac diagnostics, telemedicine and sleep therapy at LifeWatch (formerly Card Guard) and PRYM medical, respectively. Nimrod also served 6 years in various R&D roles in an advanced technological unit of the IDF Military Intelligence. Mr. Kadim holds an MBA from Tel Aviv University and a B.Sc. in Electrical Engineering from Holon Institute of Technology.



Tamar Auerbach-Nevo, PhD

Preclinical Development Manager Tamar

Tamar received her Master’s Degree in Natural Sciences from the University of Ulm, Germany. She later went to Israel to join the lab of Nobel laureate Prof. Ada Yonath, where she received her Ph.D. magna cum laude. Subsequently, Tamar continued her career in Industry. In her initial employment, she worked as Team Leader in the Analytical R&D department in InSight Pharmaceuticals, where she learned extensive analytical techniques. Subsequently, Tamar worked for a number of years at Omrix Biopharmaceuticals (a Johnson & Johnson subsidiary), where she was promoted twice to reach the rank of Staff Scientist. She was responsible for the development of innovative hemostatic solutions as well as for base business support. Since August 2017, Tamar is employed at GluSense Medical as Project Leader. In her current position, she oversees different projects related to the development of the device as well as the pre-clinical research in the company.